4.4 Article

Approach to Idiopathic Anaphylaxis in Adolescents

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Pathology

The international consensus classification of mastocytosis and related entities

Roos J. Leguit et al.

Summary: Mastocytosis is a neoplasm characterized by clonal proliferation of mast cells, which can accumulate in the skin and multiple organs, leading to various clinical presentations. According to the 2022 international consensus classification, mastocytosis can be divided into a benign form confined to the skin and a malignant form with systemic involvement.

VIRCHOWS ARCHIV (2023)

Article Allergy

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update

Marcus Maurer et al.

Summary: The revision and update of the guideline on the diagnosis and management of hereditary angioedema (HAE) provides up-to-date guidance for physicians and their patients. It aims to help make rational decisions in the management of HAE, including diagnostics, treatments, goals of treatment, management for special patient groups, and disease monitoring.

ALLERGY (2022)

Article Allergy

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study

Marcus Maurer et al.

Summary: The long-term safety and re-treatment efficacy of ligelizumab 240 mg in patients with chronic spontaneous urticaria were demonstrated, with the majority of patients achieving complete response after 52 weeks. Ligelizumab was well-tolerated with most adverse events being mild or moderate, and consistent with the core study results.

ALLERGY (2022)

Article Allergy

Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer study

Diego Alvarado et al.

Summary: In this study, CDX-0159, an anti-KIT monoclonal antibody, was found to effectively suppress MCs and showed safety and long antibody exposure in healthy volunteers. Importantly, CDX-0159 also demonstrated dose-dependent profound suppression of plasma tryptase, indicating systemic MC suppression or ablation.

ALLERGY (2022)

Article Allergy

An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria

Sabine Altrichter et al.

Summary: This study aimed to evaluate the safety and efficacy of Lirentelimab in patients with chronic urticaria. The results showed that Lirentelimab could improve symptoms and reduce disease activity, demonstrating good clinical efficacy.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Review Allergy

Prevalence, Management, and Anaphylaxis Risk of Cold Urticaria: A Systematic Review and Meta-Analysis

Connor Prosty et al.

Summary: Cold urticaria has a high prevalence among patients with chronic inducible urticaria and chronic urticaria, and it is commonly managed with H1-antihistamines. Some patients receive omalizumab treatment. There is a high prevalence of anaphylaxis among patients with cold urticaria.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Allergy

The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria

Torsten Zuberbier et al.

Summary: The updated international guideline for urticaria was developed jointly by multiple international organizations, with participants from 50 countries and international societies, aiming to provide expert guidance on diagnostic and therapeutic approaches for different subtypes of urticaria.

ALLERGY (2022)

Article Allergy

EAACI guideline: Anaphylaxis (2021 update)

Antonella Muraro et al.

Summary: The updated guideline on anaphylaxis emphasizes early recognition and prompt use of intramuscular adrenaline as first-line management. It also recommends comprehensive training for people at risk of anaphylaxis and improving healthcare professionals' management skills. Additionally, the urgent need for clinical trials to improve patient management in anaphylaxis is highlighted.

ALLERGY (2022)

Article Allergy

Hereditary alpha tryptasemia is not associated with specific clinical phenotypes

Madeleine B. Chollet et al.

Summary: This study found that the prevalence of H alpha T in a random biorepository population was 7.5% and in patients with mastocytosis was 18%. There were no differences in clinical symptomology or medical history between individuals with H alpha T and controls. Elevated baseline serum tryptase was the only consistent phenotypic marker for H alpha T in this study.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Review Allergy

Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions

Jonathan J. Lyons et al.

Summary: Measurement of mast cell tryptase levels in serum has practical value in the diagnosis and management of mast cell disorders and severe systemic reactions. Recent research has discovered that individuals with elevated basal serum tryptase levels often have an increased gene copy number of TPSAB1, which encodes alpha-tryptase. This genetic trait, known as hereditary alpha-tryptasemia, affects about 6% of the population. In clinical practice, baseline tryptase levels should be considered when diagnosing mastocytosis, and variability in baseline levels should be taken into account when diagnosing a systemic allergic reaction. Individuals with symptomatic mast cell-associated disorders or reactions and a baseline serum tryptase level exceeding 6.5 ng/mL should be considered for tryptase genotyping. This review provides detailed information on how to utilize the results of such testing in the diagnosis and management of mastocytosis and anaphylaxis.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Letter Allergy

Pediatric-onset aspirin-exacerbated respiratory disease: Clinical characteristics, prevalence, and response to dupilumab

Jillian C. Bensko et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Education, Scientific Disciplines

How to evaluate the patient with a suspected mast cell disorder and how/when to manage symptoms

Cem Akin

Summary: Mast cell disorders consist of mastocytosis and mast cell activation syndromes. Mastocytosis is a rare clonal disorder driven by KIT D816V mutation, while mast cell activation syndromes encompass a diverse group of disorders with clonal or nonclonal etiologies. Hematologists may be consulted to assist in the diagnosis and management of mast cell disorders.

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2022)

Review Allergy

Food-Dependent Exercise-Induced Wheals, Angioedema, and Anaphylaxis: A Systematic Review

Kanokvalai Kulthanan et al.

Summary: Food-dependent exercise-induced allergic reactions have diverse clinical manifestations, triggers, and response to treatment, highlighting the importance of avoiding culprit foods and allergological diagnostic workup.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Review Allergy

Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group

Karl Sotlar et al.

Summary: Pathology plays a crucial role in the diagnosis and monitoring of systemic mastocytosis, and the classification of different variants. Challenges may arise in the diagnosis of advanced variants, requiring integrated analysis of morphological and clinical data.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2022)

Article Allergy

Drug allergy: A 2022 practice parameter update

David A. Khan et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Allergy

Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria

Marcus Maurer et al.

Summary: Remibrutinib is highly effective in the treatment of CSU, with rapid onset of action and a favorable safety profile.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

IgE-neutralizing UB-221 mAb, distinct from omalizumab and ligelizumab, exhibits CD23-mediated IgE downregulation and relieves urticaria symptoms

Be-Sheng Kuo et al.

Summary: Over the past 20 years, only omalizumab has been approved as an anti-IgE antibody for treating asthma and chronic spontaneous urticaria (CSU). This report introduces UB-221, a newer class of anti-IgE antibody with different characteristics compared to omalizumab and ligelizumab. UB-221 demonstrates superior efficacy in CD23-mediated downregulation of IgE production and exhibits strong IgE-neutralizing activity.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Immunology

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation

Wouter Korver et al.

Summary: This study reveals the inhibitory effect of Siglec-8 mAb on MC activity. Siglec-8 regulates Fc epsilon RI-induced phosphorylation events through phosphatase recruitment and interaction with Fc epsilon RI gamma, resulting in global inhibition of MCs.

FRONTIERS IN IMMUNOLOGY (2022)

Article Hematology

Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis

Georg Greiner et al.

Summary: The study showed that in patients with mastocytosis, those with HαT had higher levels of tryptase and were more likely to experience hymenoptera venom hypersensitivity reactions and severe cardiovascular mediator-related symptoms/anaphylaxis. This suggests that HαT could be a novel emerging robust biomarker in mastocytosis.
Article Immunology

A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation

Julia Schanin et al.

Summary: Studies have shown that therapeutic treatment with anti-Siglec-8 monoclonal antibody can inhibit mast cell activation, reduce recruitment of immune cells and airway inflammation, and alleviate lung fibrosis in non-allergic disease models. Additionally, anti-Siglec-8 treatment can also suppress neutrophil influx and cytokine production by inhibiting mast cell activation.

MUCOSAL IMMUNOLOGY (2021)

Review Allergy

Cold urticaria - What we know and what we do not know

Natalya Maltseva et al.

Summary: Cold urticaria is a chronic condition characterized by allergic reactions to cold, with mechanisms involving autoallergens and proinflammatory mediators. Diagnosis relies on patient history and cold stimulation testing, while treatment includes cold avoidance and medication use. Many questions regarding ColdU remain unanswered, highlighting the need for further research to improve management strategies.

ALLERGY (2021)

Article Pathology

Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation Syndrome

Matthew J. Hamilton et al.

Summary: This study found that patients with the H alpha T mutation have increased numbers of MCs in the duodenum, which may contribute to the prevalent gastrointestinal manifestations seen in individuals with this genetic trait.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Review Allergy

Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 Gene

Jyoti Sharma et al.

Summary: Hereditary Angioedema is a genetic disorder characterized by gene mutations and recurrent swelling episodes. Normal C1 inhibitor HAE patients show similar clinical manifestations, but rare subtypes may have different characteristics. Whole-exome sequencing is expected to help identify new genetic defects in HAE.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)

Review Biochemistry & Molecular Biology

Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021

Magdalena Lange et al.

Summary: Pediatric mastocytosis is a heterogeneous disease caused by mutations in the KIT proto-oncogene, characterized by accumulation of mast cells in the skin, commonly seen in children. Treatment mainly involves avoidance of triggers, medication, and preparation for severe allergic reactions.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Allergy

A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis

Melody C. Carter et al.

Summary: The study aimed to determine the efficacy of omalizumab in managing patients with frequent episodes of IA, showing a trend of efficacy in the treatment group but no statistically significant differences. Overall, omalizumab was safely administered to a difficult-to-treat patient population with IA.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Medicine, Research & Experimental

Remibrutinib (LOU064): A selective potent oral BTK inhibitor with promising clinical safety and pharmacodynamics in a randomized phase I trial

Martin Kaul et al.

Summary: The study found that remibrutinib exhibited good pharmacokinetics and pharmacodynamics in humans, with over 95% blood BTK occupancy achieved at doses equal to or greater than 30 mg. It also showed promising efficacy in individuals with asymptomatic atopic diathesis.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)

Article Allergy

Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology

Matthew P. Giannetti et al.

Summary: Patients with MCAS-T exhibit unique morphologic and histologic features in bone marrow, including larger, hypogranular MCs located in paratrabecular and perivascular areas, associated with bone marrow eosinophilia. All patients available for tryptase genotyping were confirmed to have HaT, indicating that elevated tryptase levels in MCAS-T patients are caused by this genetic trait.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Review Allergy

Clinical relevance of inherited genetic differences in human tryptases Hereditary alpha-tryptasemia and beyond

Sarah C. Glover et al.

Summary: Hereditary alpha-tryptasemia (H alpha T) is a common autosomal dominant genetic trait associated with mast cell-associated disorders and reactions. While many individuals with H alpha T may not exhibit symptoms, in some cases it can lead to more severe anaphylactic reactions and other clinical symptoms.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

Review Allergy

Inherited and acquired determinants of serum tryptase levels in humans

Jonathan J. Lyons

Summary: This study provides insights into the interpretation of serum tryptase levels, highlighting the genetic basis for elevated BST levels and the differences between acute and chronic increases in serum tryptase levels. Understanding these distinctions is crucial for the correct interpretation of this clinical biomarker.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)

Review Medicine, General & Internal

Capillary leak syndrome: State of the art in 2021

A. Bichon et al.

Summary: Capillary leak syndrome (CLS) is a multifaceted and potentially lethal disease characterized by diffuse severe edema and hypovolemia. It is mainly triggered by drugs, malignancy, infections, and inflammatory diseases. The pathophysiology involves severe endothelial disruption, and treatment includes symptomatic care and prophylactic use of immunoglobulins.

REVUE DE MEDECINE INTERNE (2021)

Article Allergy

Update on latex allergy: New insights into an old problem

Claudio A. S. Parisi et al.

Summary: Despite efforts to alleviate the consequences of natural rubber latex allergy (NRLA), it remains a global health problem and a major concern in many countries' working environments. Prevalence of IgE-mediated allergy to latex proteins has decreased in developed countries, potentially leading to decreased attention from healthcare workers, while issues persist in developing countries due to lack of data and awareness. The review aims to update knowledge and provide practical recommendations from allergologists worldwide with experience in NRLA.

WORLD ALLERGY ORGANIZATION JOURNAL (2021)

Article Allergy

The Role of Basophil Activation Test in Drug Allergy

R. Fernandez-Santamaria et al.

Summary: BAT is a reliable in vitro test for evaluating drug hypersensitivity reactions, but its immunological mechanisms and standardisation are still challenging. Recent studies have suggested new potential applications of BAT, such as assessing IgE-mediated mechanisms, studying cross-reactivity between drugs, and monitoring desensitisation procedures.

CURRENT TREATMENT OPTIONS IN ALLERGY (2021)

Article Medicine, General & Internal

Factitious Disorder Masquerading as a Life-Threatening Anaphylaxis

Resha Khanal et al.

Summary: Factitious disorder is a psychiatric disorder where patients intentionally fabricate symptoms to assume the sick role. In this case, a 23-year-old female was diagnosed with major depressive disorder instead of malingering disorder. Early multidisciplinary involvement and evidence-based studies are crucial in managing factitious disorders.

JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS (2021)

Article Allergy

Idiopathic anaphylaxis yardstick Practical recommendations for clinical practice

Melody C. Carter et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2020)

Review Allergy

Anxiety and food allergy: A review of the last two decades

Laura Polloni et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2020)

Review Allergy

Oral mite anaphylaxis: who, when, and how?

Mario Sanchez-Borges et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Review Allergy

Clinical Management of Exercise-Induced Anaphylaxis and Cholinergic Urticaria

Mario Geller

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2020)

Review Allergy

Can patients with oral allergy syndrome be at risk of anaphylaxis?

Isabel J. Skypala

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2020)

Article Allergy

World allergy organization anaphylaxis guidance 2020

Victoria Cardona et al.

WORLD ALLERGY ORGANIZATION JOURNAL (2020)

Article Allergy

Summation anaphylaxis: A challenging diagnosis

Mauro Calvani et al.

PEDIATRIC ALLERGY AND IMMUNOLOGY (2020)

Editorial Material Allergy

Food oral immunotherapy is superior to food avoidance-CON

Camille Braun et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)

Editorial Material Allergy

Report of a Case of IgE-Mediated Anaphylaxis to Fenugreek

S. Aurich et al.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY (2019)

Article Allergy

Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome

Peter Valent et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Article Allergy

Omalizumab Therapy for Mast Cell-Mediator Symptoms in Patients with ISM, CM, MMAS, and MCAS

Richard Lemal et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Review Allergy

Pollen food allergy syndrome (PFAS): A review of current available literature

Geoffrey Carlson et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)

Review Allergy

Preventing iatrogenic gelatin anaphylaxis

Yike Jiang et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)

Review Allergy

Anaphylaxis in adolescents

Pasquale Comberiati et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Review Medicine, General & Internal

Pollen-Food Allergy Syndrome: A not so Rare Disease in Childhood

Carla Mastrorilli et al.

MEDICINA-LITHUANIA (2019)

Article Allergy

AAAAI Mast Cell Disorders Committee Work Group Report: Mast cell activation syndrome (MCAS) diagnosis and management

Catherine R. Weiler et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Allergy

Exploring the Diagnosis and Profile of Cannabis Allergy

Ine Ilona Decuyper et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Article Medicine, General & Internal

Ligelizumab for Chronic Spontaneous Urticaria

Marcus Maurer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Review Allergy

Cannabis-Associated Asthma and Allergies

J. M. Chatkin et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)

Review Allergy

A Comprehensive Review on Mustard-Induced Allergy and Implications for Human Health

Akanksha Sharma et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2019)

Article Allergy

Self-reported adverse reactions associated with mycoprotein (Quorn-brand) containing foods

Michael F. Jacobson et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2018)

Letter Gastroenterology & Hepatology

Energy drinks and adolescents - A hepatic health hazard?

Sophie Robin et al.

JOURNAL OF HEPATOLOGY (2018)

Article Allergy

Diagnostic Accuracy of Urinary LTE4 Measurement to Predict Aspirin-Exacerbated Respiratory Disease in Patients with Asthma

Grazyna Bochenek et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2018)

Review Allergy

Food-induced fatal anaphylaxis: From epidemiological data to general prevention strategies

Guillaume Pouessel et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2018)

Review Chemistry, Applied

Common food colorants and allergic reactions in children: Myth or reality?

Gavriela Feketea et al.

FOOD CHEMISTRY (2017)

Article Allergy

An analysis of anaphylaxis cases at a single pediatric emergency department during a 1-year period

Christopher D. Wright et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2017)

Article Allergy

Sublingual immunotherapy A focused allergen immunotherapy practice parameter update

Matthew Greenhawt et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2017)

Review Allergy

Histamine (Scombroid) Fish Poisoning: a Comprehensive Review

Charles Feng et al.

CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2016)

Letter Allergy

IgE-dependent mechanism and successful desensitization of erythritol allergy

Shiro Sugiura et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2016)

Letter Allergy

Annatto seed hypersensitivity in a pediatric patient

Nicole B. Ramsey et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2016)

Letter Allergy

Coping and posttraumatic stress symptoms in children with food allergies

Danielle Weiss et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2016)

Review Allergy

Epidemiology of severe anaphylaxis: can we use population-based data to understand anaphylaxis?

Paul J. Turner et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Article Allergy

Anaphylaxis in children and adolescents: The European Anaphylaxis Registry

Linus B. Grabenhenrich et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Article Allergy

Human IgE-independent systemic anaphylaxis

Fred D. Finkelman et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)

Article Allergy

Prospective Validation of the NIAID/FAAN Criteria for Emergency Department Diagnosis of Anaphylaxis

Caitlin E. Loprinzi Brauer et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2016)

Review Medicine, General & Internal

Angiotensin-converting Enzyme Inhibitor-induced Angioedema

Shira Bezalel et al.

AMERICAN JOURNAL OF MEDICINE (2015)

Article Allergy

Anaphylaxis-a practice parameter update 2015

Phillip Lieberman et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2015)

Review Dermatology

Paediatric mastocytosis: a systematic review of 1747 cases

C. Meni et al.

BRITISH JOURNAL OF DERMATOLOGY (2015)

Review Allergy

Anaphylaxis in adolescents: a potential tripartite management framework

Bright I. Nwaru et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Article Allergy

The alpha-gal story: Lessons learned from connecting the dots

John W. Steinke et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Review Allergy

Bee Pollen-Induced Anaphylaxis: A Case Report and Literature Review

Jeong-Hee Choi et al.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2015)

Review Allergy

Sensitivity to food additives, vaso-active amines and salicylates: a review of the evidence

Isabel J. Skypala et al.

CLINICAL AND TRANSLATIONAL ALLERGY (2015)

Review Gastroenterology & Hepatology

A guide to midgut neuroendocrine tumours (NETs) and carcinoid syndrome

Vincent T. F. Cheung et al.

FRONTLINE GASTROENTEROLOGY (2015)

Article Hematology

Sensitive KIT D816V mutation analysis of blood as a diagnostic test in mastocytosis

Thomas Kristensen et al.

AMERICAN JOURNAL OF HEMATOLOGY (2014)

Article Medicine, General & Internal

Anaphylaxis: Underdiagnosed, Underreported, and Undertreated

David A. Sclar et al.

AMERICAN JOURNAL OF MEDICINE (2014)

Article Allergy

Munchausen Stridor-A Strong False Alarm of Anaphylaxis

Sami L. Bahna et al.

ALLERGY ASTHMA & IMMUNOLOGY RESEARCH (2014)

Article Allergy

A Novel Scoring System to Distinguish Vocal Cord Dysfunction From Asthma

Russell S. Traister et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2014)

Letter Allergy

A case of anaphylaxis to erythritol diagnosed by CD203c expression-based basophil activation test

Shiro Sugiura et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2013)

Review Allergy

Treatment of patients who present after an episode of anaphylaxis

Phil Lieberman

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2013)

Article Allergy

Anaphylaxis from ingestion of mites: Pancake anaphylaxis

Mario Sanchez-Borges et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)

Editorial Material Medicine, General & Internal

Anaphylaxis caused by mosquito allergy in systemic mastocytosis

Nadine Reiter et al.

LANCET (2013)

Letter Allergy

Anaphylaxis following cilantro ingestion

David W. Unkle et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2012)

Article Otorhinolaryngology

Antihypertensive drug-induced angioedema causing upper airway obstruction in children

Katherine A. Hom et al.

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2012)

Article Primary Health Care

Strategies for living with the risk of anaphylaxis in adolescence: qualitative study of young people and their parents

Michael Gallagher et al.

PRIMARY CARE RESPIRATORY JOURNAL (2012)

Review Dermatology

Diagnosis and Treatment of Cutaneous Mastocytosis in Children Practical Recommendations

Mariana Castells et al.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2011)

Review Allergy

Spice allergy

James L. Chen et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2011)

Article Allergy

Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations

Matthew J. Hamilton et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Article Allergy

Allergen immunotherapy: A practice parameter third update

Linda Cox et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)

Article Peripheral Vascular Disease

Long-term follow-up of 111 patients with angiotensin-converting enzyme inhibitor-related angioedema

Laura Beltrami et al.

JOURNAL OF HYPERTENSION (2011)

Article Allergy

Sensitization to lupine flour: is it clinically relevant?

N. W. de Jong et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2010)

Review Allergy

Interactions between helminth parasites and allergy

Philip J. Cooper

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2009)

Review Allergy

Understanding the mechanisms of anaphylaxis

Richard D. Peavy et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2008)

Article Medicine, General & Internal

Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis

Peter Vadas et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Allergy

Adverse reactions to food additives

BG Wilson et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2005)

Article Allergy

Anaphylactic reaction to inulin: First identification of specific IgEs to an inulin protein compound

P Franck et al.

INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2005)

Article Pediatrics

Clinical features and anaphylaxis in children with cold urticaria

AA Alangari et al.

PEDIATRICS (2004)

Review Allergy

Psyllium-associated anaphylaxis and death: a case report and review of the literature

B Khalili et al.

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2003)

Letter Medicine, General & Internal

Anaphylaxis from inulin in vegetables and processed food.

F Gay-Crosier et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)